Breast Cancer Prevention

Breast cancer is the most common malignancy among women around the world. In fact, in Spain, the most frequent tumors in women are those of Mama and Colón.

It is estimated that approximately one in eight women will suffer from breast cancer throughout life. In fact, in Spain about 26,000 cases are diagnosed per year, which represents almost 30% of all tumors that affect the female sex.

Breast cancer, worldwide, is the first cause of death from cancer in women.

RISK FACTORS

Various hormonal and genetic factors can influence the risk of breast cancer, including:

Primary prevention

It is essential to maintain a healthy life habits, including:

Secondary prevention

Realization of mammograms and ultrasounds allows you to detect breast cancer and increases the chances of receiving a less aggressive treatment with more chances of cure.

Radiological examinations should be done from the recommended ages, not before, to avoid subjecting the breast to unnecessary and excessive irradiation. Specifically, it is currently recommended to perform periodic mammograms for all women between 45 and 69 years old.

In other ages, the performance of early detection tests must be evaluated individually, in each woman, based on their risk factors, such as previous breast pathologies, density and family history.

Breast self-exploration as a single method of early detection is not useful. However, the appearance of palpable nodules or lumps in the breast should always be consulted with a doctor.

If there are several cases of cancer in the family, especially breast and ovarian, and, above all, if they affect close relatives, ask us about the possibility of carrying out a study and genetic advice through tests to detect if you have a genetic mutation (BRCA 1 and BRCA 2).

If so, the therapeutic possibilities are frequent revisions, mastectomy (removal of the breast or part of it) and prophylactic oophorectomy (extirpation of the ovaries) before disease and chemo prevention occur.

What is breast cancer screening?

It is the diagnosis of early stage disease, without symptoms, in order to control the situation, with less aggressive treatments to gain years of life and reduce mortality.

The test par excellence is mammography.

The Ul increases the sensitivity of the mammography by 30% to detect breast cancers, but it also increases false positives, which is not recommended in the case of screening.

The MRI Nuclear is more sensitive than mammography, but it is not recommended as a screening test except in women at high risk of hereditary breast cancer, due to its high cost and the high rate of false positives.